Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Accumulated Expenses (2022 - 2025)

Neuraxis (NRXS) posted Accumulated Expenses of $692683.0 for Q4 2025, down 64.59% sequentially from $2.0 million in Q3 2025, and down 45.08% YoY from $1.3 million in Q4 2024.

Neuraxis (NRXS) Accumulated Expenses (2022 - 2025) Analysis & Trends

Neuraxis has reported Accumulated Expenses for 4 years, with the latest figure at $692683.0 in Q4 2025.

  • Quarterly Accumulated Expenses fell 45.08% year-over-year to $692683.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $692683.0 (down 45.08% YoY) and the FY2025 annual result came in at $692683.0, down 45.08% from the prior year.
  • Accumulated Expenses retreated to $692683.0 in Q4 2025 per NRXS's latest filing, from $2.0 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $2.0 million in Q3 2025 and troughed at $66648.0 in Q4 2023.
  • A 4-year average of $656479.0 and a median of $578097.5 in 2023 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2023 and 2024: Accumulated Expenses slumped 92.01% in 2023, then surged 1792.51% in 2024.
  • Over 4 years, Accumulated Expenses stood at $834062.0 in 2022, then plunged by 92.01% to $66648.0 in 2023, then soared by 1792.51% to $1.3 million in 2024, then plunged by 45.08% to $692683.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $692683.0, $2.0 million, and $66648.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Neuraxis 74.54 Mn 66.21 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 692,683.00
Sep 30, 2025 1.96 Mn
Jun 30, 2025 66,648.00
Mar 31, 2025 66,648.00
Dec 31, 2024 1.26 Mn
Sep 30, 2024 1.17 Mn
Jun 30, 2024 66,648.00
Mar 31, 2024 816,480.00
Dec 31, 2023 66,648.00
Sep 30, 2023 417,390.00
Jun 30, 2023 463,512.00
Dec 31, 2022 834,062.00